Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920621 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 876
- Enrollment target
NCT00920621 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 876 participants.
The verdict
NCT00920621, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 876 participants
- Enrollment target
Study Summary
Vitamin D supplementation given to pregnant women will prevent asthma in their offspring and children.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D 3 cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 876 participants |
| Start Date | 2009-09 |
| Est. Completion | 2023-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00920621
The ClinicalTrials.gov registry entry for NCT00920621 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 876 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.
NCT00920621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00920621 about?
NCT00920621 is a clinical study titled "Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)". Vitamin D supplementation given to pregnant women will prevent asthma in their offspring and children.
What is the current status of trial NCT00920621?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 876 participants. The study started on 2009-09. Estimated completion is 2023-08.
What interventions are being tested in trial NCT00920621?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D 3 cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00920621?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.